Indefinite Delivery Contract 75F40125D00013
Award Date
9/3/25
Last Date to Order
8/31/31
Federal Agency
Food and Drug Administration
Awardee
Fujifilm Irvine Scientific, Inc.
Ultimate Awardee
Not listed
PSC Category
B529 - Special Studies/Analysis- Scientific Data
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Inventory
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract was awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell (iPSC)-derived human cell products. The contract supports the supply of a wide range of specialized cell types derived from iPSCs, such as cardiomyocytes, neurons, astrocytes, hepatocytes, and macrophages. These cell...
This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Ihrc, Incorporated, a small disadvantaged and woman-owned business. The $49.5 million contract provides the FDA with specialized technical services to support safety, occupational health, and laboratory operations across its facilities. Key services include safety engineering, industrial hygiene, laboratory science, laboratory security, and occupational health support. The...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Fujifilm Healthcare Americas Corp, a division of Fujifilm Holdings Corporation. The contract has a ceiling value of $768,000,000 and a period of performance from August 2017 to August 2027. The contract enables federal agencies, primarily the Department of Defense and Department of Veterans Affairs, to procure a wide range of medical capital equipment and associated maintenance...
The indefinite delivery contract (IDC) HHSF223201710066C was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to the Mississippi State Department of Health (MSDH) Finance & Accounts Division. The single-award IDC has a ceiling value of $617,617.33 and an ultimate completion date of July 22, 2022. It is for MQSA (Mammography Quality Standards Act) inspections, which support the FDA's mission of overseeing the safety and quality of medical devices. Under this...
This indefinite delivery contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Vivo Biosciences, Inc., a small business contractor, on February 1, 2010. The contract has a ceiling value of $11,500 and a period of performance through January 31, 2013. The purpose of this IDC is to provide 3D growth study analysis services. The contract was set aside for small businesses. Based on the information provided, it does not appear that any specific task...
This indefinite delivery contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian agency, to Brigham & Women's Hospital Inc., a leading academic medical center and research institution affiliated with Harvard Medical School. The $100,000,000 multiple-award IDC is for research and development services at FDA facilities, with no small business set-aside. The contract has included several delivery orders for specialized medical research and clinical services in support...
This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc., a prominent for-profit organization specializing in healthcare data, analytics, and clinical research services. The contract has a ceiling value of $16,803,000.00 and a period of performance from August 20, 2025, to August 21, 2027. The purpose of this IDC is to provide the FDA's Center for Drug Evaluation and Research with comprehensive access to outpatient...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Food and Drug Administration (FDA), a civilian federal agency, to Iqvia Government Solutions Inc., a for-profit organization specializing in healthcare data, analytics, and research services. The contract has a ceiling value of $4,463,492.67 and a period of performance extending to July 14, 2030. The primary objective of this contract is to provide the FDA with comprehensive hospital inpatient and emergency department drug...
This indefinite delivery contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Fefa, LLC, an 8(a) certified small disadvantaged business, for other professional services. The contract has a ceiling value of $4,000,000 and a period of performance from September 2011 to September 2017. Under this IDC, Fefa has been issued multiple firm-fixed price delivery orders to provide a variety of professional services to the FDA, including maintenance and...
This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $992,022 IDC provides for the delivery of NextSeq 500 High Output Reagent Kits to support the FDA's nucleic acid sequencing needs, with no set-aside provisions. Three delivery orders have been issued against the IDC, valued at $38,896, $193,380, and $237,188 respectively, for the purchase of...